Change in High-Density Lipoprotein Cholesterol and Incident Coronary Heart Disease in Apparently Healthy Male Physicians

American Journal of Cardiology

Volumn 102, Issue 12, 2008, Pages 1663-1667

  Rahilly Tierney, Catherine ^a,b   Bowman, Thomas S ^a,b   Djoussé, Luc ^b   Sesso, Howard D ^a,b   Gaziano, J Michael ^a,b  

^a Hlth Serv Research and Development   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; DIABETES MELLITUS; HAZARD RATIO; HEART DEATH; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CHOLESTEROL, HDL; COHORT STUDIES; CORONARY DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICIANS; RISK;

EID: 57649087124     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.07.055     Document Type: Article

References (29)

1. Belanger C., Buring J.E., Cook N., Aberlein K., Goldhaber S.Z., Gordon D., Hennekins C.H., Mayrent S.L., Peto R., Rosner B., et al., Steering Committee of the Physician's Health Study Research Group. Final report on the aspirin component of the ongoing Physician's Health Study. N Engl J Med 10 (1989) 1425-1505
2. Hennekens C.H., Buring J.E., Manson J.E., Stampfer M., Rosner B., Cook N.R., Belanger C., Lamotte R., Gaziano J.M., Ridker P.M., Willett W., and Peto R. Lack of effect of long-term supplementation with beta-carotene on incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334 (1996) 1145-1149
3. Sesso H.D., Gaziano J.M., VanDenBurgh M., Hennekens C.H., Glynn R.J., and Buring J.E. Comparison of baseline characteristics and mortality experience of participants and non-participants in a randomized clinical trial: the Physician's Health Study. Control Clin Trials 23 (2002) 686-702
4. Scranton R., Sesso H.D., Stampfer M.J., Levenson J.W., Buring J.E., and Gaziano J.M. Predictors of 14-year changes in the total cholesterol to high-density lipoprotein cholesterol ratio in men. Am Heart J 147 (2004) 1033-1038
5. Wilson P.W., Anderson K.M., Harris T., Kannel W.B., and Castelli W.P. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol 49 (1994) M252-M257
6. Ferrara A., Barrett-Connor E., and Shan J. Total, LDL, HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. Circulation 96 (1997) 37-43
7. Garry P.J., Hunt W.C., Koehler K.M., VanderJagt D.J., and Vellas B.J. Longitudinal study of dietary intakes and plasma lipids in healthy elderly men and women. Am J Clin Nutr 55 (1992) 682-688
8. Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., Kirby A., Sourjina T., Peto R., Collins R., Simes J., and Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomized trials of statins. Lancet 366 (2005) 1267-1278
9. Cannon C.P., Steinberg B.A., Murphy S.A., Mega J.L., and Braunwald E. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol 48 (2006) 438-445
10. Deedwania P., Stone P.H., Merz N.B., Cosin-Aguilar J., Koylan N., Luo D., Ouyan P., Piotrowicz R., Schenck-Gustafsson K., Sellier P., et al. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE). Circulation 115 (2007) 700-707
11. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., and Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62 (1977) 707-714
12. Castelli W.P., Garrison R.J., Wilson P.W.F., Abbott R.D., Kalousdian S., and Kannel W.B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256 (1986) 2835-2838
13. Gordon D.J., Probstfield J.L., Garrison R.J., Neaton J.D., Castelli W.P., Knoke J.D., Jacobs D.R., Bandiwala S., and Tyroler H.A. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79 (1989) 8-15
14. Gaziano J.M., Buring J.E., Breslow J.L., Goldhaber S.Z., Rosner B., VanDenBurgh M., Willett W., and Hennekens C.H. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 329 (1993) 1829-1834
15. Stampfer M.J., Sacks F.M., Salvini S., Willett W.C., and Hennekens C.H. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 325 (1991) 373-381
16. Miller N.E., Thelle D.S., Forde O.H., and Mjos O.D. The Tromsø Heart-Study: high-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet 1 (1977) 965-968
17. Perova N.V., Organov R.G., Williams D.H., Irving S.H., Abernathy J.R., Deev A.D., Shestov D.B., Zhukovsky G.S., Davis C.E., and Tyroler H.A. Association of high-density-lipoprotein cholesterol with mortality and other risk factors for major chronic noncommunicable disease in samples of US and Russian men. Ann Epidemiol 5 (1995) 179-185
18. Jacobs D.R., Mebane I.L., Bangdiwala S.I., Criqui M.H., and Tyroler H.A. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 131 (1990) 32-47
19. Gordon D.J., Knoke J., Probstfield J.L., Superko R., and Tyroler H.A. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial. Circulation 74 (1986) 1217-1225
20. Svensvold I., Urdal P., Thürmer H., Tverdal A., Lund-Larsen P.G., and Foss O.P. High-density lipoprotein cholesterol and coronary, cardiovascular, and all cause mortality among middle-aged Norwegian men and women. Eur Heart J 13 (1992) 1155-1163
21. Enger S.C., Hjermann I., Foss O.P., Helgeland A., Holme I., Leren P., and Norum K.R. High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study. Artery 5 (1979) 170-181
22. Shaten B.J., Kuller L.H., and Neaton J.D. Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years. MRFIT Research Group. Prev Med 20 (1991) 655-659
23. Multiple Risk Factor Intervention Trial Research Group. Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Prev Med 15 (1986) 254-273
24. Singh I.M., Shishehbor M.H., and Ansell B.J. High-density lipoprotein as a therapeutic target. JAMA 298 (2007) 786-798
25. Goldenberg I., Goldbourt U., Boyko V., Behar S., Reicher-Reiss H., and BIP Study Group. Relation between on-treatment increments in serum high-density lipoprotein cholesterol levels and cardiac mortality in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Am J Cardiol 97 (2006) 466-471
26. Weisweiler P. Plasma lipoproteins and lipase and lecithin: cholesterol acyltransferase activities in obese subjects before and after weight reduction. J Clin Endocrinol Metab 65 (1987) 969-973
27. Dattilo A.M., and Kris-Etherton P.M. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 56 (1992) 320-328
28. Burke V., Beilin L.J., Cutt H.E., Mansour J., Williams A., and Mori T.A. A lifestyle program for treated hypertensives improved health-related behaviors and cardiovascular risk factors, a randomized controlled trial. J Clin Epidemiol 60 (2007) 133-141
29. Ellison R.C., Zhang Y., Qureshi M.M., Knox S., Arnett D.K., Province M.A., and Investigators of the NHLBI Family Heart Study. Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study. Am Heart J 147 (2004) 529-535